Amplius Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Amplius Wealth Advisors's PFE Position: Q2 2026 in Review
Amplius Wealth Advisors increased its Pfizer (PFE) stake by 39% in Q2 2026, buying an estimated $104K and bringing the position to 14,251 shares worth $343K. The position accounts for 0.03% of the portfolio, ranked #161.
Amplius Wealth Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.94M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Amplius Wealth Advisors held 14,251 shares of Pfizer worth $343K as of Q2 2026.
- Amplius Wealth Advisors bought 3,966 Pfizer shares in Q2 2026, an estimated $104K.
- Pfizer made up 0.03% of Amplius Wealth Advisors's portfolio in Q2 2026, its #161 holding.
- Amplius Wealth Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Amplius Wealth Advisors's Pfizer position peaked at $1.94M in Q4 2021.
- 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Amplius Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.